Patents by Inventor Elsa Merit Reyes-Reyes

Elsa Merit Reyes-Reyes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for modulating DNMT1 inhibitor activity
    Patent number: 9737493
    Abstract: Some aspects of the invention include attenuating DNMT1 inhibitor activity in an animal comprising administering an antioxidant. Other aspects of the invention include methods comprising administering a composition comprising a DNMT1 inhibitor and an antioxidant. In some instances in the methods, the animal is undergoing a treatment for cancer. Additional aspects of the invention include compositions comprising a DNMT1 inhibitor and an antioxidant.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: August 22, 2017
    Assignee: University of Louisville Research Foundation, Inc.
    Inventors: Francesca R. Salipur, Paula J. Bates, Elsa Merit Reyes-Reyes, Bo Xu, Gerald B. Hammond
  • Compounds, compositions, pharmaceutical compositions, and methods of use
    Patent number: 9492428
    Abstract: Certain embodiments of the invention include compositions comprising a compound of Formula (I), and salts, isomers, and derivatives thereof. Pharmaceutical compositions of some embodiments of the present invention comprise a compound of Formula (I), and salts, isomers, and derivatives thereof. Other embodiments of this invention include methods for treating disease (e.g., cancer) and methods for administering a compound of Formula (I), and salts, isomers, and derivatives thereof.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: November 15, 2016
    Assignee: University of Louisville Research Foundation, Inc.
    Inventors: Gerald B. Hammond, Zhuang Jin, Paula J. Bates, Elsa Merit Reyes-Reyes, Abraham Vaisberg
  • COMPOSITIONS AND METHODS FOR MODULATING DNMT1 INHIBITOR ACTIVITY
    Publication number: 20150238439
    Abstract: Some aspects of the invention include attenuating DNMT1 inhibitor activity in an animal comprising administering an antioxidant. Other aspects of the invention include methods comprising administering a composition comprising a DNMT1 inhibitor and an antioxidant. In some instances in the methods, the animal is undergoing a treatment for cancer. Additional aspects of the invention include compositions comprising a DNMT1 inhibitor and an antioxidant.
    Type: Application
    Filed: September 6, 2013
    Publication date: August 27, 2015
    Inventors: Francesca R. Salipur, Paula J. Bates, Elsa Merit Reyes-Reyes, Bo Xu, Gerald B. Hammond
  • COMPOUNDS, COMPOSITIONS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE
    Publication number: 20150025129
    Abstract: Certain embodiments of the invention include compositions comprising a compound of Formula (I), and salts, isomers, and derivatives thereof. Pharmaceutical compositions of some embodiments of the present invention comprise a compound of Formula (I), and salts, isomers, and derivatives thereof. Other embodiments of this invention include methods for treating disease (e.g., cancer) and methods for administering a compound of Formula (I), and salts, isomers, and derivatives thereof.
    Type: Application
    Filed: November 16, 2012
    Publication date: January 22, 2015
    Inventors: Gerald B. Hammond, Zhuang Jin, Paula J. Bates, Elsa Merit Reyes-Reyes, Abraham Vaisberg
  • METHODS OF INCREASING MACROPINOCYTOSIS IN CANCER CELLS
    Publication number: 20130065227
    Abstract: This disclosure describes methods of stimulating macropinocytosis in cancer cells.
    Type: Application
    Filed: March 4, 2011
    Publication date: March 14, 2013
    Inventors: Paula J. Bates, Elsa Merit Reyes-Reyes